Fingerprint
Dive into the research topics of 'Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancer
J. A. Sparano, E. L. Schwartz, K. M. Salva, M. F. Pizzillo, S. Wadler, P. H. Wiernik
Research output: Contribution to journal › Article › peer-review
13
Scopus
citations